Signal active
Organization
Contact Information
Overview
Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines.
About
Biotechnology, Health Care, Pharmaceutical, Manufacturing, Biopharma
2018
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
Innoforce Pharmaceuticals headquartered in Asia, operates in the Biotechnology, Health Care, Pharmaceutical, Manufacturing, Biopharma sector. The company focuses on Biotechnology and has secured $6.2B in funding across 40 round(s). With a team of 101-250 employees, Innoforce Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Innoforce Pharmaceuticals, raised $58.8M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
2
9
0
$154.9M
Details
2
Innoforce Pharmaceuticals has raised a total of $154.9M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Early Stage Venture | 96.0M | ||
2021 | Early Stage Venture | 58.8M |
Investors
Innoforce Pharmaceuticals is funded by 13 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Liu Zeng | - | FUNDING ROUND - Liu Zeng | 58.8M |
Innoforce Pharmaceuticals | - | FUNDING ROUND - Innoforce Pharmaceuticals | 58.8M |
China Highrun Capital Limited | - | FUNDING ROUND - China Highrun Capital Limited | 58.8M |
Innoforce Pharmaceuticals | - | FUNDING ROUND - Innoforce Pharmaceuticals | 58.8M |
Recent Activity
There is no recent news or activity for this profile.